Skip to content

NIH R21 Budget: $275K Total, $200,000 Max in Any Year

Updated 16 official sources

Quick Answer: An NIH R21 budget can request up to $275,000 in direct costs for the whole 2-year project, with no more than $200,000 in either year, according to NIH's [R21 activity-code…

Full answer and how we checked it

An NIH R21 budget can request up to $275,000 in direct costs for the whole 2-year project, with no more than $200,000 in either year, according to NIH's R21 activity-code page (opens in a new tab) and the Parent R21 notice PA-25-304 (opens in a new tab) (checked November 15, 2026). Indirect (F&A) costs aren't part of that cap: domestic applicants request direct costs in $25,000 modules on NIH's modular budget form and add F&A separately, so a $75,000 and $200,000 split fits while $200,000 in both years doesn't. R21s can't be renewed, the Research Strategy is limited to 6 pages, preliminary data aren't required, and NIH funded 10.9% of R21 applications in FY2025 (1,454 of 13,316, NIH RePORT (opens in a new tab)).

This guide is for: investigators and research administrators sizing an NIH R21 budget, or deciding whether an R21 fits better than an R01 or R03.

Data note: Budget limits, project period, renewal status, page limit, preliminary-data policy, parent-branch posture, and institute participation were checked November 15, 2026 against NIH R21 activity-code guidance, active Parent R21 NOFOs PA-25-304 and PA-25-306, NIH's modular budget instructions, NIH RePORT Data Book table 206, NIAID R01/R21 FY2024 data, and NIH simplified review policy. The specific NOFO controls when its terms differ from the standard R21 characteristics.

In this guide

For the current deadlines, award data, and institute participation details, start with the live NIH R21 parent clinical-trial-required program page or the NIH R21 parent clinical-trial-not-allowed program page. The no-trial notice itself, its 21 institutes and its expiration date are covered in the PA-25-304 guide.

R21 budget decisionCurrent NIH ruleWhat to do before drafting
Total direct-cost ceilingUp to $275,000 across the full project periodBuild both budget periods together. Do not treat $275,000 as an annual amount.
Single-year ceilingNo more than $200,000 in either yearA $75,000 and $200,000 split can fit. A $200,000 and $200,000 split cannot.
Budget formPHS 398 Modular Budget for domestic organizations, in $25,000 modules$275,000 is 11 modules. Foreign organizations use the detailed R&R budget.
Indirect (F&A) costsNot counted in the $275,000; requested separately at the institution's rateGet the F&A figure from your sponsored programs office before setting aims.
Project periodUp to 2 yearsUse an R01 or another mechanism if the core result needs a longer period.
RenewalNot allowedBudget for a bounded proof point, not continuing program support.
Research StrategyUp to 6 pages, unless the NOFO says otherwiseCut aims before compressing explanation. The scope must fit the page and budget limits.
Next standard due dates (checked November 15, 2026)Resubmission or revision: November 16, 2026, then March 16 and July 16, 2027. New: February 16, June 16 and October 18, 2027 (October 16 is a Saturday)Confirm the NOFO's Key Dates in PA-25-304 (opens in a new tab); every other activity code is in NIH grant deadlines.
Parent branchPA-25-304 is clinical trial not allowed; PA-25-306 is clinical trial requiredPick the trial branch and confirm institute participation before building the budget.

The NIH R21 grant looks like an easier path to funding: smaller budget, shorter page limit, no preliminary data required. The data says otherwise. NIH funded 10.9% of R21 applications in FY2025, the same rate as the R01 activity code that year (4,074 of 37,423) in NIH RePORT table 206, and at NIAID the FY2024 R21 success rate was 16.0%, almost the same as the 15.8% R01-equivalent rate.

If you're a researcher considering an R21 for exploratory or pilot work, a department chair advising junior faculty on mechanism selection, or a grants administrator reviewing R21 budgets, this guide covers what you need to know.

This page covers how to build the R21 budget, what the R21 is designed for, what the success rate data shows, which institutes participate, and the specific situations where it's the right choice and where it isn't.

From Manusights, our sister product

Applying for an R01 or R21? Manusights offers an AI critique of your application against NIH's published review criteria: $149 for a new R01 or R21, $199 for a resubmission. Back within 3 business days of your upload.

Order a grant review

How to Build an R21 Budget: Splits That Fit

An R21 budget has to pass two tests at once: no year above $200,000 in direct costs, and no more than $275,000 across both years. For a domestic applicant, each year is also requested in whole $25,000 modules on the PHS 398 Modular Budget form (opens in a new tab), so an even $137,500 split isn't available; the closest even split is 5 and 6 modules. Grantsights analysis of the $275,000 and $200,000 limits and the $25,000 module rule gives this screen of 8 common splits:

Year 1 direct costsYear 2 direct costsTwo-year totalModules (year 1 + year 2)Fits the R21 limits?
$125,000$150,000$275,0005 + 6Yes
$150,000$125,000$275,0006 + 5Yes
$75,000$200,000$275,0003 + 8Yes, year 2 is at the annual cap
$200,000$75,000$275,0008 + 3Yes, year 1 is at the annual cap
$100,000$100,000$200,0004 + 4Yes, $75,000 under the total
$225,000$50,000$275,0009 + 2No, year 1 is over $200,000
$150,000$150,000$300,0006 + 6No, $25,000 over the total
$200,000$200,000$400,0008 + 8No, $125,000 over the total

Indirect (F&A) costs sit outside this table. The modular form takes them in Section B at your institution's rate, so the award your institution receives is larger than the direct-cost total. Two more budget facts affect cash flow. NIAID's FY2026 funding policy (opens in a new tab) says all unsolicited domestic R21s and R03s will be multi-year funded for the full project duration. And a common mistake is front-loading year 1 for equipment, then finding year 2 can't pay the personnel the aims need.

The success rate behind those budgets is on the NIH R21 success rate page, by year and institute, and the module rules are explained in the NIH modular budget guide.


Next route: Compare R21 with nearby NIH grant routes, the R01 path, and the NIGMS MIRA R35 record. Use this page for R21 fit and the route pages for mechanism choice.

First-screen route map: use the NIH hub when you are still choosing a mechanism, the R01 route when the project already has a testable central hypothesis and strong preliminary evidence, the Parent R21 no-trial route for exploratory work without a clinical trial, and the Parent R21 clinical-trial-required route only when at least one clinical trial is proposed.

Get research funding calls by email

About once a week, we email open research funding calls with a real deadline, from federal agencies such as NIH and NSF, picked for research institutions. One click to unsubscribe.

No spam. Unsubscribe anytime.

Grantsights Source Review and Decision Evidence

Source review by Grantsights: we checked the current NIH R21 activity-code page (opens in a new tab), active NIH Parent R21 branches (opens in a new tab), NIAID R01/R21 award-count guidance (opens in a new tab), NIDDK R21 participation guidance (opens in a new tab), NIH RePORT success-rate tables (opens in a new tab), and NIH simplified review policy (opens in a new tab) on November 15, 2026. The practical gap is that official pages state each rule separately, while an applicant must make one combined budget, duration, trial-status, and institute-participation decision.

Source checkedWhat it provesApplicant action
Active Parent R21 NOFOsClinical trial status and institute participation control fit, including PA-25-304 (opens in a new tab) and PA-25-306 (opens in a new tab) branch updatesConfirm the branch and institute before drafting
NIAID R01/R21 FY2024 countsR21 and R01-equivalent rates were nearly tied at NIAID, so R21 is not an easier hedgeDo not use R21 only because it is shorter
NIH simplified review policyReview still tests importance, rigor, and feasibility for due dates on or after January 25, 2025Scope the work to a 2-year proof point
USASpending.govPrior awards show topic and institute patternsCheck whether your institute funds R21s in this field

November 15 current-source rule: the parent R21 branch is the first decision, not the page limit. PA-25-304 owns no-trial parent R21 intent, PA-25-306 owns clinical-trial-required parent R21 intent, and institute notices can add or remove participation after the parent announcement posts. Check the branch and participating institute before writing aims.

According to NIH, the R21 is intended for exploratory or developmental research and does not allow renewal. According to NIAID FY2024 award counts, R21 and R01-equivalent success rates were nearly tied (16.0% and 15.8%), so the R21 is not an easier route for early stage investigators, whose NIH priority applies to R01-equivalents. According to NIH, the standard R21 direct-cost limit is $275,000 over a 2-year project period for many parent opportunities. According to Grants.gov, each Parent R21 branch lists participating institutes, and non-participating institutes can return applications without review. According to USASpending.gov, award history can reveal whether a target institute has recently funded R21s in the same topic area.

Decision checklist:

QuestionR21 signalR01 signal
Evidence stageFeasibility evidence, limited pilot data, or a new methodStrong preliminary data and a testable central hypothesis
Time needed2 years can answer the core question3 to 5 years are needed for the aims
Career strategyExploratory result is enoughMajor independent award is needed

What Official Sources Don't Tell You

Official pages state the budget, duration, trial status, and institute participation in separate places. The combined decision is stricter: a project fits the standard R21 only when its core proof point fits within 2 years, no year exceeds $200,000 in direct costs, the total stays at or below $275,000, and the chosen institute participates in the correct Parent R21 branch. Use the Grantsights database to compare active R21 branches, and the free eligibility checker if you're unsure your institution qualifies to apply.

Based on our analysis of the NIH activity-code page, two active Parent R21 announcements, the parent-announcement table, institute guidance, and NIAID award counts, we found that the budget decision fails most clearly at the yearly split. For example, one investigator planning $125,000 in year 1 and $175,000 in year 2 is $25,000 over the project ceiling even though neither year exceeds $200,000. That plan is a bad fit for the standard cap. The better route is to cut at least $25,000 from the direct-cost plan or compare an R01 or targeted NOFO before drafting.


What the NIH R21 Is (and What It Isn't)

The R21's formal name is the Exploratory/Developmental Research Grant. NIH designed it for research directions that are genuinely too speculative to justify a full R01 - high-risk hypotheses, new collaborations between investigators who haven't worked together before, or truly preliminary explorations of an uncharted area.

Core parameters:

  • Maximum direct costs: $275,000 total over the full 2-year project period, with no more than $200,000 in any single year
  • Research Strategy page limit: 6 pages (compared to 12 pages for an R01)
  • Preliminary data: not officially required
  • Renewal: not allowed - you can't submit a competing renewal for an R21

That last point matters more than most applicants realize. The R21 is a one-time, bounded investment in an exploratory direction. It isn't designed to sustain a long-term research program.


The Counterintuitive Truth About R21 Success Rates

The assumption that a smaller, shorter grant must be easier to win is wrong, and the data is clear about it.

At NIAID in FY2024, the R21 success rate was 16.0%, while the R01-equivalent success rate was 15.8%. That narrow gap is the warning: R21 was not meaningfully easier than R01 at NIAID, even though the budget and page limit were smaller. NIAID's R21 rate dropped 5.3 percentage points from FY2023 (21.3%) to FY2024, while its R01-equivalent rate dropped 1.6 points (from 17.4%).

NIH-wide, according to NIH RePORT Data Book table 206 (opens in a new tab), the R21 and the R01 activity code both funded 10.9% of applications in FY2025:

Fiscal yearR21 reviewedR21 fundedR21 success rateR01 success rate
FY202114,9242,25715.1%17.5%
FY202212,5752,07116.5%18.9%
FY202311,1772,04418.3%18.6%
FY202411,5921,83715.8%16.2%
FY202513,3161,45410.9%10.9%

R01 here is the R01 activity code across all competing types, not NIH's broader R01-equivalent group. Institute-level R21 rates are on the R21 success rate page.

You can find NIAID's own FY2024 comparison data at niaid.nih.gov/grants-contracts/r01-and-r21-application-and-award-counts-2024 (opens in a new tab).

The smaller budget and shorter page limit don't reduce the scientific bar. They change the scope of what you're proposing, but reviewers still apply rigorous standards to the science and feasibility of what you're asking them to fund.


The Preliminary Data Question

NIH says preliminary data are not required for an R21, although applicants may include them. That rule does not remove the review of rigor and feasibility. Under NIH's simplified framework, reviewers assess whether the approach can answer the proposed question with the stated methods, timeline, team, and resources.

If you have no preliminary data, use the Research Strategy to show the scientific premise, technical feasibility, controls, decision points, and a bounded outcome that can be reached within 2 years. If the project needs an initial study before feasibility can be judged, reduce the scope or consider another mechanism rather than assuming the R21 label resolves the gap.


When R21 Is the Right Choice

The R21 makes sense in a narrow set of situations:

Genuinely novel hypothesis you can't yet justify for an R01. If you don't have the preliminary evidence to support a testable central hypothesis with 3 specific aims, but the scientific rationale for the direction is strong, R21 is appropriate.

A new collaboration between investigators in different fields with no prior joint work. R21 can fund the exploratory phase of an interdisciplinary project before it's clear enough to warrant a full R01 proposal.

Piloting a new methodology. If you're testing whether a method developed in one system translates to yours - and you don't yet know if it does - R21 is a reasonable vehicle.

Your target institute has a targeted R21 FOA aligned with your area. NCI and NIMH both issue targeted R21 FOAs for specific research priorities. A targeted FOA means your application competes in a smaller, more specific pool with explicit institute interest.

You need bridge funding with a genuinely new angle. If you're between funded periods and have a new direction that doesn't fit your existing R01 scope, an R21 can bridge the gap - but only if the science is genuinely at the exploratory stage, not just because you need money.


When R21 Is the Wrong Choice

You already have substantial preliminary data. If you have the evidence to support a testable hypothesis, you're describing an R01, not an R21. Reviewers will see the mismatch between your data and your stated mechanism and score accordingly.

You need more than $275,000 over 2 years. The budget limit is real. If your experimental plan requires more resources, you're not designing an R21.

You need more than 2 years. The standard R21 project period is up to 2 years. Do not build planned scope around a later extension. If the core question cannot be meaningfully addressed within the stated period, the mechanism does not fit.

You want to use R21 as a stepping stone to R01. This is worth its own section (see below), but the short version is: NIAID's own numbers show the R21 isn't an easier entry point, and the ESI priority stays with the R01.

Your target institute doesn't participate in the Parent R21. NIDDK is the most important example. NIDDK does NOT participate in the Parent R21 FOA. If you submit a Parent R21 to NIDDK, your application will be returned without review. NIDDK accepts R21 applications only through targeted notices; on November 15, 2026 its R21 page (opens in a new tab) listed two, both on HIV. Confirm before submitting.

You need an institution-specific career milestone. NIH mechanism rules do not determine how a university counts an award for promotion or tenure. Confirm the local policy rather than assuming an R21 satisfies the requirement.


The Stepping-Stone Warning: What NIAID's Numbers Show

NIAID funded 403 R21s from 2,524 applications in FY2024 (16.0%) and 589 R01-equivalents from 3,731 (15.8%), according to its R01 and R21 application and award counts (opens in a new tab). NIAID used to publish an article warning that R21s make slippery stepping stones; it was no longer online on November 15, 2026, but the current numbers and NIH policy make the same case.

The 2-year R21 timeline is short. By the time the work is done and published, an R01 built on it is often several years away, and the R21 can't be renewed to fill the gap.

The early-stage investigator advantage belongs to the R01. NIH's early-stage investigator policy (opens in a new tab) says ESI applications for R01-equivalent grants with meritorious scores will be prioritized for funding; R21s get no such priority. In FY2024 NIAID still set a separate, more generous R01 payline for new and early-stage investigators. Its FY2026 policy says it no longer uses a score cutoff as the basis for funding but aims for an ESI success rate at least equal to established investigators', so the priority now shows up in funding decisions rather than a published payline.

The R21 generates only modest preliminary data for a 5-year R01 hypothesis. $275,000 in direct costs over 2 years usually doesn't produce the depth of evidence that an R01 needs. Holding an R21 doesn't end ESI status (it's on NIH's list of smaller awards that keep it), but the 10-year ESI window keeps running while the R21 does.

The practical rule: if you're an ESI who could make the case for an R01, apply for the R01.


Institute-Specific R21 Participation

Participation differs by Parent R21 branch and can change through NIH notices. On November 15, 2026, the PA-25-304 no-trial branch listed 21 participating institutes and centers, including NCI, NIAID, NHLBI, NIMH, NINDS and NCATS (NCATS joined in July 2026). The PA-25-306 clinical-trial-required branch listed 17. Neither parent branch listed NIDDK or NIGMS.

NIDDK separately states that it does not participate in the Parent R21 and accepts R21 applications only through institute-specific announcements. Do not infer participation from an institute's general interest in exploratory research. Open the exact NOFO, find the participating-organizations section, and confirm that your institute appears before drafting.


The 6-Page Research Strategy Challenge

Six pages is half an R01's Research Strategy. That constraint changes how you need to write.

The most common mistake: applicants draft a full R01-length Research Strategy and then cut it to 6 pages. What remains is a compressed R01 that lacks context, jumps between concepts without adequate explanation, and fails to make the coherent argument the full version would have made.

The better approach is to design the Research Strategy from scratch at the R21 scope. Six pages should demonstrate a coherent, scientifically sound exploration that is appropriate for the budget and timeline - not a miniaturized version of a larger project. Reviewers applying R21 standards know the difference.

For a 2-year, 6-page Research Strategy, a reasonable structure includes: the scientific rationale (what gap you're filling and why it's worth filling), preliminary evidence or conceptual foundation, 2-3 focused aims that can realistically be completed in 2 years with the proposed budget, and expected outcomes.


R21 vs R03 for Early-Career Investigators

If you're an early-career investigator deciding between R21 and R03, the key distinction is budget and scope:

R03 ($50,000/year, 2 years, not renewable): better for secondary data analysis, a narrow method validation project, or very limited pilot work. The budget is appropriate for computational work, analysis, or small-scale studies that don't require major equipment or personnel.

R21 ($275,000 total over 2 years, not renewable): better for a higher-cost exploratory project with a genuine novel direction that requires more resources - laboratory personnel, equipment time, or a small-scale experimental study. If you're weighing a real submission this cycle, compare that summary with the live NIH R21 parent program page.

Both mechanisms: holding an R03 or R21 does NOT end your ESI status. Both are on NIH's list of smaller grants that keep ESI status (opens in a new tab), so you can hold either and still apply as an ESI for your first R01.

The ESI calculation still favors the R01, though. If you're within the ESI window and can make the scientific case for an R01 application, NIH's ESI priority for R01-equivalent applications makes that the stronger choice. See our full comparison of R01 vs R21 vs R03 for the decision framework.


What Reviewers Actually Look for in an R21

An R21 isn't graded on a curve because it's smaller. The review criteria under the Simplified Review Framework (effective January 25, 2025, per NOT-OD-24-010) apply: Importance of the Research, Rigor and Feasibility, and Expertise and Resources.

What changes for R21 review is the calibration of scope. Reviewers expect the proposed work to be appropriate for a 2-year, $275,000 project. An R21 that proposes to do the same amount of work as a 5-year R01 won't score well - not because the science is bad, but because the feasibility claim is implausible.

The Rigor and Feasibility factor is where most R21 applications succeed or fail. For exploratory research, rigor means: clear hypothesis (even if speculative), appropriate controls, a statistical plan or decision framework for what you'll do with the results, and a contingency if the primary approach doesn't work. Feasibility means the work is actually doable in the proposed timeline with the proposed budget and team.


Why the FY2024 NIAID R21 Data Is a Mechanism-Choice Warning

According to NIAID, it received 2,524 R21 applications and made 403 awards in FY2024, a 16.0% success rate. Its R01-equivalent table reported 3,731 applications and 589 awards, a 15.8% success rate. NIAID's FY2024 paylines were the 10th percentile for established-investigator R01s and an impact score of 28 for R21s; for FY2026 it no longer uses a score cutoff. Those institute-specific figures do not establish an NIH-wide rule, but they do reject the assumption that a shorter application was materially easier to fund at NIAID that year.

Use those rates as a mechanism-choice check, not as a forecast for one application. Confirm the target institute, branch, and topic fit, then ask whether the project has a useful bounded outcome within the R21 budget and period. If the project already needs an R01-scale test or timeline, the smaller mechanism does not fix the mismatch.

What NIH's R21 Program Page Doesn't Tell You About NIH R21 Grants

The $275,000 figure is a total direct-cost ceiling across the project, not a yearly allowance. The extra constraint is the $200,000 maximum in any one year. A $75,000 first year and $200,000 second year can fit the standard cap. Two $200,000 years cannot.

The official pages also do not combine the budget rule with route ownership. Before finalizing costs, confirm whether the project includes a clinical trial and whether the target institute participates in that branch. A mathematically valid budget still fails the fit screen when the branch or institute is wrong.


Sources


Best follow-up

Compare R21 with nearby NIH paths

Use the NIH hub to decide whether R21, R01, R03, R35, K awards, fellowships, SBIR, or STTR is the better fit.

Free. No payment on this step.

Next stepCompare NIH grant routesSee NIH grants

Frequently Asked Questions

What is the budget limit for an NIH R21 grant?

Up to $275,000 in direct costs for the whole project period of up to 2 years, with no more than $200,000 in any single year, according to NIH's R21 activity-code page and the Parent R21 notices PA-25-304 and PA-25-306 (checked November 15, 2026). The $275,000 is a two-year total, not an annual amount, and a specific NOFO can set a different limit.

How much money is an R21 grant, including indirect costs?

The $275,000 cap covers direct costs only. Indirect (F&A) costs are requested separately, in Section B of the PHS 398 Modular Budget form, at the applicant institution's rate, so the total award is larger than $275,000. How much larger depends on the institution's negotiated rate and which costs fall in its F&A base, so ask your sponsored programs office for the number before you set aims.

Does an R21 use a modular budget?

Usually yes. NIH's modular budget instructions say domestic organizations requesting $250,000 or less in direct costs per budget period use the PHS 398 Modular Budget form, in modules of $25,000. Because an R21 year can't exceed $200,000, a domestic R21 is normally modular: $275,000 is 11 modules, split for example as 5 and 6 or 3 and 8. Foreign organizations use the detailed R&R budget.

Can I request $200,000 in both years of an R21?

No. Two $200,000 years total $400,000, which is over the $275,000 project limit even though neither year is over the $200,000 annual limit. Splits such as $75,000 and $200,000, or $125,000 and $150,000, fit both limits.

What is the NIH R21 success rate?

NIH funded 10.9% of R21 applications in FY2025, 1,454 of 13,316 reviewed, down from 15.8% in FY2024, according to NIH RePORT Data Book table 206 (checked November 15, 2026). At NIAID, the FY2024 R21 rate was 16.0%, almost the same as its 15.8% R01-equivalent rate. The full table by year and institute is on the Grantsights R21 success rate page.

Do I need preliminary data for an NIH R21?

No. PA-25-304 says preliminary data are not required for R21 applications but may be included if available. Reviewers still assess rigor and feasibility, so explain the scientific premise, controls, decision points, and whether the work fits the proposed time and resources.

Can I use an R21 as a stepping stone to an R01?

It's a weak plan for most early-stage investigators. NIH's early-stage investigator policy prioritizes meritorious R01-equivalent applications, not R21s; an R21 can't be renewed; and at NIAID in FY2024 the R21 success rate (16.0%) was no better than the R01-equivalent rate (15.8%). If you can make the case for an R01, the R01 keeps the ESI priority and runs up to 5 years.

Does an R21 count toward NIH's limit of six applications a year?

Yes. NOT-OD-25-132 limits each PI to six new, renewal, resubmission or revision applications per calendar year, for applications submitted to the September 25, 2025 receipt date and later. Only T activity codes and R13 conference grants are excluded, so R21 submissions count.

Which NIH institutes participate in the Parent R21?

On November 15, 2026, PA-25-304 (no clinical trial) listed 21 institutes and centers, including NCI, NIAID, NHLBI, NIMH, NINDS and NCATS, and PA-25-306 (clinical trial required) listed 17. Neither listed NIDDK or NIGMS. NIDDK accepts R21s only through its own targeted notices, currently two on HIV.

When is the next NIH R21 deadline?

Resubmissions and revisions are due November 16, 2026, then March 16 and July 16, 2027. New R21 applications are due February 16, June 16 and October 18, 2027 (October 16 is a Saturday, so the date moves to the next business day), at 5:00 PM local time, according to NIH's standard due dates page (checked November 15, 2026).

Last updated November 15, 2026. Corrected November 15, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.